New Drug Discovery – Putting Patients First – Asrar Qureshi’s Blog Post #1304

Asrar Qureshi’s Blog Post #1304 highlights Astellas Pharma’s innovative approach to drug development, emphasizing patient-centric decision-making. The company shifts from traditional therapeutic areas to a model based on biology, modality, and disease. Astellas champions learning from failures, cross-functional teams, and harnessing automation to enhance patient outcomes and operational efficiency.
Share
View Post

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
View Post

Basic Mistakes Job Seekers Make – Asrar Qureshi’s Blog Post 1052

Asrar Qureshi’s blog highlights the evolving landscape of job seeking, contrasting older and younger generations’ views on career loyalty. It outlines common mistakes candidates make, including unclear job-switching purpose, lack of research, generic applications, and poor interview preparation. Emphasizing clarity, customization, and professionalism boosts job-seeking success.
Share
View Post

Rise of Syphilis as Health Emergency – Asrar Qureshi’s Blog Post #1035

Asrar Qureshi’s blog highlights the alarming rise of syphilis in the US and Europe, referencing data from the WHO and CDC. The infection, causing serious health complications, is also prevalent in Pakistan, where existing statistics reveal significant prevalence rates. Additionally, societal taboos hinder awareness and treatment efforts, exacerbating public health concerns.
Share
View Post

Pharma & the Future: Powered by Partnership & Patient Experience – Asrar Qureshi’s Blog Post 993

This blogpost provides a summary of a new Whitepaper on patient engagement within the pharmaceutical industry. It discusses the shift towards prioritizing patients, driven by global and local initiatives, and the challenges and opportunities in measuring the impact of patient engagement. It also highlights the importance of strategic partnerships and technology in driving the industry’s future success.
Share